Featured Topics
Featured Products
Events
S&P Global Offerings
Featured Topics
Featured Products
Events
S&P Global Offerings
Featured Topics
Featured Products
Events
S&P Global Offerings
Featured Topics
Featured Products
Events
Financial and Market intelligence
Fundamental & Alternative Datasets
Government & Defense
Banking & Capital Markets
Economy & Finance
Energy Transition & Sustainability
Technology & Innovation
Podcasts & Newsletters
Financial and Market intelligence
Fundamental & Alternative Datasets
Government & Defense
Banking & Capital Markets
Economy & Finance
Energy Transition & Sustainability
Technology & Innovation
Podcasts & Newsletters
10 Feb, 2022
By Tyler Udland
Accounts have received allocations of the $265 million first-lien term loan backing the buyout of Emerald EMS by Crestview Partners, according to sources. The term loan, which was upsized by $15 million, priced in line with talk at a spread of 625 basis points over the secured overnight financing rate plus a credit spread adjustment, with a 1% floor and an original issue discount of 98 via lead arrangers UBS and Barclays. The maturity of the term loan was shorted to six-years, from seven years at launch, and the loan will amortize at 2.5% per annum. The facility will be governed by a total net leverage covenant. Financing will also include a $45 million revolving credit facility due 2027. Emerald EMS, based in Salem, N.H., is a high-tech electronics manufacturing services and design firm with end users in the aerospace and defense, industrial controls, medical, semiconductor sectors, and power and infrastructure.
Terms:
| Borrower | Emerald EMS |
| Issue | $265 million first-lien term loan |
| UoP | LBO |
| Spread | Sofr+CSA+625 |
| Sofr+CSA floor | 1.00% |
| Price | 98 |
| Tenor | 6-year |
| YTM | 7.93% |
| Four-year yield | 8.08% |
| Call protection | 101 hard call for 12 months |
| Corporate ratings | B-/B3 |
| Facility ratings | B-/B3 |
| Recovery ratings | 3 |
| Financial covenants | Total net leverage covenant |
| Arrangers | UBS/Barc |
| Admin agent | UBS |
| Px Talk | Sofr+625/1%/98 |
| Sponsor | Crestview Partners |
| Notes | CSA: 10/15/25 bps (1-month, 3-month, 6month rates). Call protection revised from 6 months of 101 soft call. Tenor shortened from 7-year. Amortizes at 2.5% per annum. Upsized by $15 million. |